Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 1Neuroblastoma 1Brain Neoplasms 1

Interventions

X-Rays 6Temozolomide 6Specimen Handling 6Nuclear Medicine Department, Hospital 6Magnetic Resonance Spectroscopy 6Biopsy 6Phantoms, Imaging 5Irinotecan 4Cyclophosphamide 4dinutuximab 3ulixertinib 2tipifarnib 2selpercatinib 2saponin QA-21V1 2olaparib 2larotrectinib 2ivosidenib 2fludarabine phosphate 2erdafitinib 2ensartinib 2Topotecan 2trametinib 1tazemetostat 1talazoparib 1palbociclib 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1fludarabine 1dabrafenib 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Interleukin-15 × 30 days × Clear all
NCT01875601 2026-05-22

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
16 enrolled
CNSSarcoma

Brain Neoplasms, Neuroblastoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡